TITLE

Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study

AUTHOR(S)
de Keyser, C E; Eijgelsheim, M; Hofman, A; Sijbrands, E J G; Maitland-van der Zee, A-H; van Duijn, C M; Uitterlinden, A G; Witteman, J C M; Ch Stricker, B H
PUB. DATE
February 2011
SOURCE
Pharmacogenomics Journal;Feb2011, Vol. 11 Issue 1, p72
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The objective of this study was to investigate whether common variation in genes involved in lipid metabolism modify the effect of statins on serum total cholesterol concentration. Statin users were identified in the Rotterdam Study, a prospective population-based cohort study of subjects >55 years of age. We studied the association between single nucleotide polymorphisms (SNPs) in genes involved in lipid metabolism and total cholesterol response to statin therapy, using linear regression analysis and adjusting for potential confounders. Replication was performed in an independent extended cohort of the Rotterdam Study. Genotype data and total cholesterol concentrations after start of statin therapy were available for 554 newly started statin users. Two SNPs were associated with a significantly higher cholesterol concentration under statin therapy: SNP rs1532624 in the CETP gene (β: 0.141 mmol l−1, P=0.004 per additional allele) and SNP rs533556 in the APOA1 gene (β: 0.138 mmol l−1, P=0.005 per additional allele). In the replication sample, only the CETP rs1532624 SNP again showed a significant association. The SNPs were not related to baseline total cholesterol in non-statin users. In conclusion, we found that the CETP rs1532624 polymorphism is associated with cholesterol response to statin therapy in a cohort of elderly subjects in the general population.
ACCESSION #
57544952

 

Related Articles

  • Recent advances in statins and the kidney. Oda, Hiroaki; Keane, William F. // Kidney International Supplement;Jul1999, Issue 71, pS-2 

    Examines the correlation between the progression of renal disease and dyslipidemia. Role of a statin class of lipid-lowering agents in the biology of inflammation; Involvement of statins in the signaling pathways; Participation of macrophages in the uptake and metabolism of lipids.

  • Inversions with deletions and duplications. Gordon, Alasdair J.E.; Halliday, Jennifer A. // Genetics;May95, Vol. 140 Issue 1, p411 

    Discusses the inversion of DNA sequence with deletions and duplications. Nascent leading-strand misalignment upon the lagging-strand template during DNA replication; Misalignment-realignment phenomena during DNA replication.

  • Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability. La Spada, A. R.; Peterson, K. R.; Meadows, S. A.; McClain, M. E.; Jeng, G.; Chmelar, R. S.; Haugen, H. A.; Chen, K.; Singer, M. J.; Moore, D.; Trask, B. J.; Fischbeck, K. H.; Clegg, C. H.; McKnight, G. S. // Human Molecular Genetics;Jun98, Vol. 7 Issue 6, p959 

    Provides insights into the molecular basis of trinucleotide repeat instability in humans. Correlation between the rate of allele expansion and disease size range; Formation of DNA structures during replication; Relationship between maternal transmission of CAG nucleotide tract and repeat...

  • Changes in PPAR gene expression and myocardial tolerance to ischaemia: relevance to pleiotropic effects of statins. Ravingerová, Táńa; Adameová, Adriana; Kelly, Tara; Antonopoulou, Efthymia; Pancza, Dezider; Ondrejčáková, Mária; Khandelwal, Vinoth Kumar Megraj; Čarnická, Slávka; Lazou, Antigone // Canadian Journal of Physiology & Pharmacology;Dec2009, Vol. 87 Issue 12, p1028 

    Peroxisome proliferator-activated receptors (PPAR), which are key transcriptional regulators of lipid metabolism and energy production, have been suggested to play an important role in myocardial ischaemia-reperfusion (I/R) injury. Their role in cardioprotection, however, is not yet fully...

  • Regulation of Cholesterol Biosynthesis and Absorption: Ultimate Management of Dyslipidemia with Statin and Ezetimibe. Yoshida, Masayuki // Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry;Jun2008, Vol. 8 Issue 2, p177 

    Coronary heart disease (CHD) has been one of the leading causes of death in United States, Japan and EU countries. A large bodies of clinical evidence suggests a causative role for elevated cholesterol in atherosclerosis, and supports treatment of hyperlipidemia [1-3]. Nonetheless, fewer than...

  • New approach to dyslipidaemia treatment.  // British Journal of Hospital Medicine (17508460);Apr2009, Vol. 70 Issue 4, p189 

    The article evaluates the efficacy of treating hypercholesterolaemia or dyslipidaemia with a combination of nicotinic acid and laropiprant, and simvastatin. This treatment resulted in decreased low-density lipoprotein cholesterol and triglyceride and increased high-density lipoprotein...

  • Rosuvastatin. Carswell, C.I.; Plosker, G.L.; Jarvis, B. // Drugs;2002, Vol. 62 Issue 14, p2075 

    â–´ Rosuvastatin is a hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor used in the treatment of patients with dyslipidaemia. Rosuvastatin is not extensively metabolised and has a low propensity for drug interactions. â–´ In well designed trials of between 6 and 52 weeks'...

  • Atorvastatin.  // Reactions Weekly;4/25/2009, Issue 1249, p9 

    The article presents a case study of a 63-year-old man with a lipid metabolism disorder who developed focal myositis during long-term atorvastatin treatment. He experienced an acute onset of left-sided hip pain during his treatment and x-ray revealed a slight narrowing of the joint space. The...

  • Comprehensive lipid management now possible.  // British Journal of Hospital Medicine (17508460);Sep2009, Vol. 70 Issue 9, p496 

    The article investigates the effectiveness of tredative in treating dyslipidaemia. It features the pharmacologic ingredients of tredative including laropiprant and nicotinic acid. In addition, it is considered as more effective in lipid management compared to statin monotherapy. It cites that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics